Epigenetic deregulation of miR-29a and miR-1256 by isoflavone contributes to the inhibition of prostate cancer cell growth and invasion

References

• Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012; 62:10 - 29; http://dx.doi.org/10.3322/caac.20138; PMID: 22237781
   PubMed Web of Science ®Google Scholar
• Jerónimo C, Bastian PJ, Bjartell A, Carbone GM, Catto JW, Clark SJ, et al. Epigenetics in prostate cancer: biologic and clinical relevance. Eur Urol 2011; 60:753 - 66; http://dx.doi.org/10.1016/j.eururo.2011.06.035; PMID: 21719191
   PubMed Web of Science ®Google Scholar
• Formosa A, Lena AM, Markert EK, Cortelli S, Miano R, Mauriello A, et al. DNA methylation silences miR-132 in prostate cancer. Oncogene 2012; http://dx.doi.org/10.1038/onc.2012.14; PMID: 22310291
   PubMed Web of Science ®Google Scholar
• Agirre X, Martínez-Climent JA, Odero MD, Prósper F. Epigenetic regulation of miRNA genes in acute leukemia. Leukemia 2012; 26:395 - 403; http://dx.doi.org/10.1038/leu.2011.344; PMID: 22143672
   PubMed Web of Science ®Google Scholar
• Lopez-Serra P, Esteller M. DNA methylation-associated silencing of tumor-suppressor microRNAs in cancer. Oncogene 2012; 31:1609 - 22; http://dx.doi.org/10.1038/onc.2011.354; PMID: 21860412
   PubMed Web of Science ®Google Scholar
• Wu WK, Law PT, Lee CW, Cho CH, Fan D, Wu K, et al. MicroRNA in colorectal cancer: from benchtop to bedside. Carcinogenesis 2011; 32:247 - 53; http://dx.doi.org/10.1093/carcin/bgq243; PMID: 21081475
   PubMed Web of Science ®Google Scholar
• Li Y, Kong D, Wang Z, Sarkar FH. Regulation of microRNAs by natural agents: an emerging field in chemoprevention and chemotherapy research. Pharm Res 2010; 27:1027 - 41; http://dx.doi.org/10.1007/s11095-010-0105-y; PMID: 20306121
   PubMed Web of Science ®Google Scholar
• Kasinski AL, Slack FJ. Epigenetics and genetics. MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy. Nat Rev Cancer 2011; 11:849 - 64; http://dx.doi.org/10.1038/nrc3166; PMID: 22113163
   PubMed Web of Science ®Google Scholar
• Huang J, Plass C, Gerhauser C. Cancer chemoprevention by targeting the epigenome. Curr Drug Targets 2011; 12:1925 - 56; http://dx.doi.org/10.2174/138945011798184155; PMID: 21158707
   PubMed Web of Science ®Google Scholar
• Rabiau N, Trraf HK, Adjakly M, Bosviel R, Guy L, Fontana L, et al. miRNAs differentially expressed in prostate cancer cell lines after soy treatment. In Vivo 2011; 25:917 - 21; PMID: 22021684
   PubMed Web of Science ®Google Scholar
• Li Y, VandenBoom TG 2nd, Kong D, Wang Z, Ali S, Philip PA, et al. Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells. Cancer Res 2009; 69:6704 - 12; http://dx.doi.org/10.1158/0008-5472.CAN-09-1298; PMID: 19654291
   PubMed Web of Science ®Google Scholar
• Li Y, Vandenboom TG 2nd, Wang Z, Kong D, Ali S, Philip PA, et al. miR-146a suppresses invasion of pancreatic cancer cells. Cancer Res 2010; 70:1486 - 95; http://dx.doi.org/10.1158/0008-5472.CAN-09-2792; PMID: 20124483
   PubMed Web of Science ®Google Scholar
• Desjobert C, Renalier MH, Bergalet J, Dejean E, Joseph N, Kruczynski A, et al. MiR-29a down-regulation in ALK-positive anaplastic large cell lymphomas contributes to apoptosis blockade through MCL-1 overexpression. Blood 2011; 117:6627 - 37; http://dx.doi.org/10.1182/blood-2010-09-301994; PMID: 21471522
   PubMed Web of Science ®Google Scholar
• Lee KH, Lotterman C, Karikari C, Omura N, Feldmann G, Habbe N, et al. Epigenetic silencing of MicroRNA miR-107 regulates cyclin-dependent kinase 6 expression in pancreatic cancer. Pancreatology 2009; 9:293 - 301; http://dx.doi.org/10.1159/000186051; PMID: 19407485
   PubMed Web of Science ®Google Scholar
• Cui Y, Su WY, Xing J, Wang YC, Wang P, Chen XY, et al. MiR-29a inhibits cell proliferation and induces cell cycle arrest through the downregulation of p42.3 in human gastric cancer. PLoS One 2011; 6:e25872; http://dx.doi.org/10.1371/journal.pone.0025872; PMID: 21998710
   PubMedGoogle Scholar
• Zhao JJ, Lin J, Lwin T, Yang H, Guo J, Kong W, et al. microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma. Blood 2010; 115:2630 - 9; http://dx.doi.org/10.1182/blood-2009-09-243147; PMID: 20086245
   PubMed Web of Science ®Google Scholar
• Muniyappa MK, Dowling P, Henry M, Meleady P, Doolan P, Gammell P, et al. MiRNA-29a regulates the expression of numerous proteins and reduces the invasiveness and proliferation of human carcinoma cell lines. Eur J Cancer 2009; 45:3104 - 18; http://dx.doi.org/10.1016/j.ejca.2009.09.014; PMID: 19818597
   PubMed Web of Science ®Google Scholar
• Kuo TY, Hsi E, Yang IP, Tsai PC, Wang JY, Juo SH. Computational analysis of mRNA expression profiles identifies microRNA-29a/c as predictor of colorectal cancer early recurrence. PLoS One 2012; 7:e31587; http://dx.doi.org/10.1371/journal.pone.0031587; PMID: 22348113
   PubMed Web of Science ®Google Scholar
• Hatakeyama S. TRIM proteins and cancer. Nat Rev Cancer 2011; 11:792 - 804; http://dx.doi.org/10.1038/nrc3139; PMID: 21979307
   PubMed Web of Science ®Google Scholar
• Miyajima N, Maruyama S, Bohgaki M, Kano S, Shigemura M, Shinohara N, et al. TRIM68 regulates ligand-dependent transcription of androgen receptor in prostate cancer cells. Cancer Res 2008; 68:3486 - 94; http://dx.doi.org/10.1158/0008-5472.CAN-07-6059; PMID: 18451177
   PubMed Web of Science ®Google Scholar
• Ai J, Huang H, Lv X, Tang Z, Chen M, Chen T, et al. FLNA and PGK1 are two potential markers for progression in hepatocellular carcinoma. Cell Physiol Biochem 2011; 27:207 - 16; http://dx.doi.org/10.1159/000327946; PMID: 21471709
   PubMed Web of Science ®Google Scholar
• Zieker D, Königsrainer I, Traub F, Nieselt K, Knapp B, Schillinger C, et al. PGK1 a potential marker for peritoneal dissemination in gastric cancer. Cell Physiol Biochem 2008; 21:429 - 36; http://dx.doi.org/10.1159/000129635; PMID: 18453750
   PubMed Web of Science ®Google Scholar
• LaTulippe E, Satagopan J, Smith A, Scher H, Scardino P, Reuter V, et al. Comprehensive gene expression analysis of prostate cancer reveals distinct transcriptional programs associated with metastatic disease. Cancer Res 2002; 62:4499 - 506; PMID: 12154061
   PubMed Web of Science ®Google Scholar
• Li M, Zhang B, Sun B, Wang X, Ban X, Sun T, et al. A novel function for vimentin: the potential biomarker for predicting melanoma hematogenous metastasis. J Exp Clin Cancer Res 2010; 29:109; http://dx.doi.org/10.1186/1756-9966-29-109; PMID: 20701774
   PubMed Web of Science ®Google Scholar
• Zieker D, Königsrainer I, Weinreich J, Beckert S, Glatzle J, Nieselt K, et al. Phosphoglycerate kinase 1 promoting tumor progression and metastasis in gastric cancer - detected in a tumor mouse model using positron emission tomography/magnetic resonance imaging. Cell Physiol Biochem 2010; 26:147 - 54; http://dx.doi.org/10.1159/000320545; PMID: 20798498
   PubMed Web of Science ®Google Scholar
• Duan Z, Lamendola DE, Yusuf RZ, Penson RT, Preffer FI, Seiden MV. Overexpression of human phosphoglycerate kinase 1 (PGK1) induces a multidrug resistance phenotype. Anticancer Res 2002; 22:1933 - 41; PMID: 12174867
   PubMed Web of Science ®Google Scholar
• Jung Y, Shiozawa Y, Wang J, Wang J, Wang Z, Pedersen EA, et al. Expression of PGK1 by prostate cancer cells induces bone formation. Mol Cancer Res 2009; 7:1595 - 604; http://dx.doi.org/10.1158/1541-7786.MCR-09-0072; PMID: 19825988
   PubMed Web of Science ®Google Scholar
• Wang J, Ying G, Wang J, Jung Y, Lu J, Zhu J, et al. Characterization of phosphoglycerate kinase-1 expression of stromal cells derived from tumor microenvironment in prostate cancer progression. Cancer Res 2010; 70:471 - 80; http://dx.doi.org/10.1158/0008-5472.CAN-09-2863; PMID: 20068185
   PubMed Web of Science ®Google Scholar
• Tie J, Serizawa Y, Oshida S, Usami R, Yoshida Y. Short tandem repeat polymorphism in the flanking region of the human phosphoglycerate kinase gene in a Japanese population. Hum Biol 2006; 78:243 - 7; http://dx.doi.org/10.1353/hub.2006.0039; PMID: 17036931
   PubMed Web of Science ®Google Scholar
• Riley DE, Krieger JN. Short tandem repeat polymorphism linkage to the androgen receptor gene in prostate carcinoma. Cancer 2001; 92:2603 - 8; http://dx.doi.org/10.1002/1097-0142(20011115)92:10<2603::AID-CNCR1613>3.0.CO;2-4; PMID: 11745195
   PubMed Web of Science ®Google Scholar
• Sarkar FH, Li Y. Harnessing the fruits of nature for the development of multi-targeted cancer therapeutics. Cancer Treat Rev 2009; 35:597 - 607; http://dx.doi.org/10.1016/j.ctrv.2009.07.001; PMID: 19660870
   PubMed Web of Science ®Google Scholar
• Vardi A, Bosviel R, Rabiau N, Adjakly M, Satih S, Dechelotte P, et al. Soy phytoestrogens modify DNA methylation of GSTP1, RASSF1A, EPH2 and BRCA1 promoter in prostate cancer cells. In Vivo 2010; 24:393 - 400; PMID: 20668305
   PubMed Web of Science ®Google Scholar
• Majid S, Dar AA, Shahryari V, Hirata H, Ahmad A, Saini S, et al. Genistein reverses hypermethylation and induces active histone modifications in tumor suppressor gene B-Cell translocation gene 3 in prostate cancer. Cancer 2010; 116:66 - 76; PMID: 19885928
   PubMed Web of Science ®Google Scholar
• Kikuno N, Shiina H, Urakami S, Kawamoto K, Hirata H, Tanaka Y, et al. Genistein mediated histone acetylation and demethylation activates tumor suppressor genes in prostate cancer cells. Int J Cancer 2008; 123:552 - 60; http://dx.doi.org/10.1002/ijc.23590; PMID: 18431742
   PubMed Web of Science ®Google Scholar
• Fang MZ, Chen D, Sun Y, Jin Z, Christman JK, Yang CS. Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy. Clin Cancer Res 2005; 11:7033 - 41; http://dx.doi.org/10.1158/1078-0432.CCR-05-0406; PMID: 16203797
   PubMed Web of Science ®Google Scholar
• Chen Y, Zaman MS, Deng G, Majid S, Saini S, Liu J, et al. MicroRNAs 221/222 and genistein-mediated regulation of ARHI tumor suppressor gene in prostate cancer. Cancer Prev Res (Phila) 2011; 4:76 - 86; http://dx.doi.org/10.1158/1940-6207.CAPR-10-0167; PMID: 21071579
   PubMed Web of Science ®Google Scholar
• Zaman MS, Chen Y, Deng G, Shahryari V, Suh SO, Saini S, et al. The functional significance of microRNA-145 in prostate cancer. Br J Cancer 2010; 103:256 - 64; http://dx.doi.org/10.1038/sj.bjc.6605742; PMID: 20588276
   PubMed Web of Science ®Google Scholar
• Chang S, Wang RH, Akagi K, Kim KA, Martin BK, Cavallone L, et al, Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer (kConFab). Tumor suppressor BRCA1 epigenetically controls oncogenic microRNA-155. Nat Med 2011; 17:1275 - 82; http://dx.doi.org/10.1038/nm.2459; PMID: 21946536
   PubMed Web of Science ®Google Scholar
• Zhong XY, Yu JH, Zhang WG, Wang ZD, Dong Q, Tai S, et al. MicroRNA-421 functions as an oncogenic miRNA in biliary tract cancer through down-regulating farnesoid X receptor expression. Gene 2012; 493:44 - 51; http://dx.doi.org/10.1016/j.gene.2011.11.028; PMID: 22146319
   PubMed Web of Science ®Google Scholar
• Li Y, Wang Z, Kong D, Li R, Sarkar SH, Sarkar FH. Regulation of Akt/FOXO3a/GSK-3beta/AR signaling network by isoflavone in prostate cancer cells. J Biol Chem 2008; 283:27707 - 16; http://dx.doi.org/10.1074/jbc.M802759200; PMID: 18687691
   PubMed Web of Science ®Google Scholar
• Li Y, Ahmed F, Ali S, Philip PA, Kucuk O, Sarkar FH. Inactivation of nuclear factor kappaB by soy isoflavone genistein contributes to increased apoptosis induced by chemotherapeutic agents in human cancer cells. Cancer Res 2005; 65:6934 - 42; http://dx.doi.org/10.1158/0008-5472.CAN-04-4604; PMID: 16061678
   PubMed Web of Science ®Google Scholar
• Kong D, Heath E, Chen W, Cher ML, Powell I, Heilbrun L, et al. Loss of let-7 up-regulates EZH2 in prostate cancer consistent with the acquisition of cancer stem cell signatures that are attenuated by BR-DIM. PLoS One 2012; 7:e33729; http://dx.doi.org/10.1371/journal.pone.0033729; PMID: 22442719
   PubMed Web of Science ®Google Scholar